.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Metoprolol succinate - Generic Drug Details

« Back to Dashboard
Metoprolol succinate is the generic ingredient in two branded drugs marketed by Wockhardt, Dr Reddys Labs Ltd, Actavis Labs Fl Inc, Mylan Pharms Inc, Nesher Pharms, Astrazeneca Pharms, Sandoz, and Reddys, and is included in twelve NDAs. Additional information is available in the individual branded drug profile pages.

There are fifty-six drug master file entries for metoprolol succinate. Thirty-nine suppliers are listed for this compound.

Summary for Generic Name: metoprolol succinate

Tradenames:2
Patents:0
Applicants:8
NDAs:12
Drug Master File Entries: see list56
Suppliers / Packaging: see list39
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices

Pharmacology for Ingredient: metoprolol succinate

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Ltd
METOPROLOL SUCCINATE
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL090617-002Aug 1, 2012RXNo► subscribe► subscribe
Nesher Pharms
METOPROLOL SUCCINATE
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL077176-001May 14, 2008DISCNNo► subscribe► subscribe
Wockhardt
METOPROLOL SUCCINATE
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL090615-002Jul 22, 2010RXNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: metoprolol succinate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-004Feb 5, 20014,927,640*PED► subscribe
Astrazeneca Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-002Jan 10, 19924,957,745*PED► subscribe
Astrazeneca Pharms
TOPROL-XL
metoprolol succinate
TABLET, EXTENDED RELEASE;ORAL019962-004Feb 5, 20014,957,745*PED► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc